指南与共识神经技术与安全MR

ESR要点:磁敏感加权成像的实践推荐

ESR Essentials: susceptibility-weighted imaging-practice recommendations by the European Society for Magnetic Resonance in Medicine and Biology.
指南 / 共识 · Eur Radiol · 2026-10-31

该文由欧洲磁共振医学与生物学学会制定,系统推荐SWI作为高分辨率3D GRE序列,须结合原始幅度图、滤波相位图及minIP图解读,并注意Blooming伪影与厂商相位约定。核心推荐用于脑MRI,包括脑淀粉样血管病、抗淀粉样治疗中ARIA-H监测、创伤性脑损伤、多发性硬化及神经肿瘤与血管畸形;神经放射学以外仅限针对性问题解决。

要点

  • SWI须与原始幅度图、滤波相位图及minIP图联合解读,警惕Blooming伪影。
  • 脑MRI中,当出血或微血管磁敏感表现可能影响诊断或管理时应纳入SWI。
  • 神经放射学以外,SWI仅作为针对性问题解决工具,非常规序列。

核心结论

  • SWI在脑MRI多个核心场景有中至高等级证据支持,神经放射学以外应用尚待标准化。

研究设计与样本

  • 本文为欧洲磁共振医学与生物学学会制定的实践推荐,基于证据分级提出推荐意见。

关键影像表现/征象

  • SWI为高分辨率3D GRE序列,结合幅度与相位信息,提高对血液产物、铁、钙化、血栓和静脉结构的敏感性。
  • 判读时须同时查看原始幅度图、滤波相位图、后处理SWI图及最小强度投影图。
  • 应注意Blooming伪影及其他伪影,以及不同厂商的相位约定差异。

诊断标准与关键数值

  • 脑MRI推荐场景包括疑似脑淀粉样血管病、抗淀粉样治疗中ARIA-H基线与随访评估、创伤性脑损伤、多发性硬化(中央静脉征或顺磁边缘病灶临床相关时)、神经肿瘤和血管畸形。
  • 上述核心推荐场景获得中至高等级证据支持。
  • 神经放射学以外(骨肌、腹部、乳腺、盆腔和心脏成像),SWI应保留用于选择性问题解决指征。

临床应用与阅片要点

  • 脑MRI中若预期出血或微血管磁敏感表现会影响诊断或管理,应将SWI纳入扫描方案。
  • 报告时需结合原始幅度图、滤波相位图及minIP图综合判断,避免仅凭单一后处理图下结论。
  • 需注意Blooming伪影可夸大病灶范围,并留意厂商相位约定差异对判读的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Susceptibility-weighted imaging (SWI) is a high-resolution 3D gradient-echo (GRE) magnetic resonance imaging (MRI) technique that combines magnitude and phase information to increase sensitivity to blood products, iron, calcification, thrombus, and venous structures. In routine practice, SWI should be interpreted together with source magnitude images, filtered phase images, processed SWI images, and minimum-intensity projection (minIP) images, keeping in mind blooming and other artefacts, as well as vendor-dependent phase conventions. Its most established role is in brain MRI, particularly in: suspected cerebral amyloid angiopathy; baseline and follow-up assessment of amyloid-related imaging abnormalities with haemosiderin deposition (ARIA-H) during anti-amyloid therapy; traumatic brain injury; multiple sclerosis work-up, when assessment of the central vein sign or paramagnetic rim lesions is clinically relevant; neuro-oncology; and vascular malformations. Overall, these constitute the core recommended brain scenarios for SWI supported by moderate to high levels of evidence. Outside neuroradiology (e.g., musculoskeletal, abdominal, breast, pelvic, and cardiac imaging), SWI remains promising but less standardised and should currently be reserved for selected problem-solving indications. KEY POINTS: SWI should be acquired as a high-resolution 3D GRE sequence and interpreted together with source magnitude images, filtered phase images, and post-processed minIP images, keeping in mind blooming and other artefacts, as well as vendor-specific phase conventions. SWI should be included in brain MRI protocols when haemorrhagic or microvascular susceptibility findings are expected to affect diagnosis or management, especially in cerebral amyloid angiopathy, anti-amyloid therapy monitoring, traumatic brain injury, and neuro-oncology or multiple sclerosis work-up. Outside neuroradiology, SWI can be used as a targeted problem-solving adjunct rather than as a routine sequence.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Parillo M, Deistung A, Vaccarino F, et al. ESR Essentials: susceptibility-weighted imaging-practice recommendations by the European Society for Magnetic Resonance in Medicine and Biology. Eur Radiol. 2026. PMID: 42965692. doi:10.1007/s00330-026-12988-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。